C. Yuen, Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder, Nat. Neurosci, vol.20, pp.602-611, 2017.

K. Tammimies, Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder, JAMA, vol.314, pp.895-903, 2015.

M. Ronemus, I. Iossifov, D. Levy, and M. Wigler, The role of de novo mutations in the genetics of autism spectrum disorders, Nat. Rev. Genet, vol.15, pp.133-141, 2014.

S. De-rubeis, Synaptic, transcriptional and chromatin genes disrupted in autism, Nature, vol.515, pp.209-215, 2014.

S. Dong, De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder, Cell Rep, vol.9, pp.16-23, 2014.

I. Iossifov, The contribution of de novo coding mutations to autism spectrum disorder, Nature, vol.515, pp.216-221, 2014.

N. Krumm, Excess of rare, inherited truncating mutations in autism, Nat. Genet, vol.47, pp.582-588, 2015.

B. J. O'roak, Recurrent de novo mutations implicate novel genes underlying simplex autism risk, Nat. Commun, vol.5, p.5595, 2014.

H. A. Stessman, Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases, Nat. Genet, vol.49, pp.515-526, 2017.

T. Wang, De novo genic mutations among a Chinese autism spectrum disorder cohort, Nat. Commun, vol.7, p.13316, 2016.

S. J. Sanders, Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci, Neuron, vol.87, pp.1215-1233, 2015.

M. R. Geisheker, Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains, Nat. Neurosci, vol.20, pp.1043-1051, 2017.

J. A. Rosenfeld, B. P. Coe, E. E. Eichler, H. Cuckle, and L. G. Shaffer, Estimates of penetrance for recurrent pathogenic copy-number variations, Genet. Med, vol.15, pp.478-481, 2013.

D. J. Bogaert, Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes, Sci. Rep, vol.7, p.3702, 2017.

M. H. Willemsen, Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects, J. Med. Genet, vol.49, pp.179-183, 2012.

K. J. Lamar and G. L. Carvill, Chromatin remodeling proteins in epilepsy: lessons from CHD2-associated epilepsy, Front Mol. Neurosci, vol.11, p.208, 2018.

M. Wolff, Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders, Brain, vol.140, pp.1316-1336, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01668653

K. Platzer, GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects, J. Med. Genet, vol.54, pp.460-470, 2017.

M. Kintscher, C. Wozny, F. W. Johenning, D. Schmitz, and J. Breustedt, Role of RIM1? in short-and long-term synaptic plasticity at cerebellar parallel fibres, Nat. Commun, vol.4, p.2392, 2013.

J. Pitsch, The presynaptic active zone protein RIM1? controls epileptogenesis following status epilepticus, J. Neurosci, vol.32, pp.12384-12395, 2012.

R. Bernier, Disruptive CHD8 mutations define a subtype of autism early in development, Cell, vol.158, pp.263-276, 2014.

R. L. Collins, An open resource of structural variation for medical and population genetics, 2019.

E. Chérot, Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of 2 clinical units and 216 patients, Clin. Genet, vol.93, pp.567-576, 2018.

F. Martínez, High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing, J. Med. Genet, vol.54, pp.87-92, 2017.

C. Redin, Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing, J. Med. Genet, vol.51, pp.724-736, 2014.

M. Rossi, Outcomes of diagnostic exome sequencing in patients with diagnosed or suspected autism spectrum disorders, Pediatr. Neurol, vol.70, 2017.

A. T. Vulto-van-silfhout, Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems, Am. J. Hum. Genet, vol.94, pp.649-661, 2014.

C. M. Durand, Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders, Nat. Genet, vol.39, pp.25-27, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00126175

R. K. Earl, Clinical phenotype of ASD-associated DYRK1A haploinsufficiency, Mol. Autism, vol.8, p.54, 2017.